(MSCI) MSCI - Overview
Sector: Financial Services | Industry: Financial Data & Stock Exchanges | Exchange: NYSE (USA) | Market Cap: 42.352m USD | Total Return: 8% in 12m
Avg Turnover: 354M
EPS Trend: 99.6%
Qual. Beats: 3
Rev. Trend: 99.4%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
MSCI Inc. is a global provider of critical decision support tools for the investment community. The company operates through several distinct segments, offering equity indexes, portfolio risk and performance analytics, and ESG research. Its products serve as the underlying benchmarks for trillions of dollars in exchange-traded funds (ETFs) and institutional mandates.
The business model relies heavily on recurring subscription fees and asset-based licensing, which provides high visibility into future cash flows. As a dominant player in the Financial Exchanges & Data sector, MSCI benefits from significant network effects; once an index is adopted as a benchmark by institutional investors, it becomes the industry standard for performance measurement and derivative products.
Beyond traditional equities, MSCI has expanded into private asset classes and climate-risk modeling to address growing regulatory and transparency requirements. These segments provide data on private credit, real estate, and infrastructure, helping investors manage liquidity and counterparty risks across diverse portfolios.
Investors may find additional context on these performance metrics by exploring the data available on ValueRay.
- Asset-based fee growth depends on global ETF inflows and equity market appreciation
- Expansion of ESG and climate analytics drives high-margin recurring subscription revenue
- Institutional demand for private asset data accelerates diversification into alternative investment classes
- Operating margin stability relies on scalable technology infrastructure and global data acquisition costs
| Net Income: 1.32b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.28 > 0.02 and ΔFCF/TA 0.70 > 1.0 |
| NWC/Revenue: -6.76% < 20% (prev -7.90%; Δ 1.13% < -1%) |
| CFO/TA 0.29 > 3% & CFO 1.59b > Net Income 1.32b |
| Net Debt (6.31b) to EBITDA (1.99b): 3.17 < 3 |
| Current Ratio: 0.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (73.4m) vs 12m ago -5.66% < -2% |
| Gross Margin: 82.86% > 18% (prev 0.82%; Δ 8.20k% > 0.5%) |
| Asset Turnover: 59.50% > 50% (prev 54.67%; Δ 4.82% > 0%) |
| Interest Coverage Ratio: 7.67 > 6 (EBITDA TTM 1.99b / Interest Expense TTM 232.5m) |
| A: -0.04 (Total Current Assets 1.39b - Total Current Liabilities 1.61b) / Total Assets 5.55b |
| B: 1.03 (Retained Earnings 5.68b / Total Assets 5.55b) |
| C: 0.33 (EBIT TTM 1.78b / Avg Total Assets 5.44b) |
| D: 0.68 (Book Value of Equity 5.63b / Total Liabilities 8.32b) |
| Altman-Z'' = 5.99 = AAA |
| DSRI: 1.06 (Receivables 883.2m/749.2m, Revenue 3.24b/2.92b) |
| GMI: 0.99 (GM 82.86% / 82.11%) |
| AQI: 0.97 (AQ_t 0.71 / AQ_t-1 0.73) |
| SGI: 1.11 (Revenue 3.24b / 2.92b) |
| TATA: -0.05 (NI 1.32b - CFO 1.59b) / TA 5.55b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of May 28, 2026, the stock is trading at USD 603.47 with a total of 582,860 shares traded.
Over the past week, the price has changed by +4.46%,
over one month by +2.48%,
over three months by +5.91% and
over the past year by +8.00%.
MSCI has received a consensus analysts rating of 3.95. Therefore, it is recommended to buy MSCI.
- StrongBuy: 7
- Buy: 5
- Hold: 6
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 685.4 | 13.6% |
P/E Trailing = 33.2386
P/E Forward = 29.5858
P/S = 13.0738
P/B = 37.5687
P/EG = 1.8735
Revenue TTM = 3.24b USD
EBIT TTM = 1.78b USD
EBITDA TTM = 1.99b USD
Long Term Debt = 6.40b USD (from longTermDebt, last quarter)
Short Term Debt = 25.1m USD (from shortTermDebt, last quarter)
Debt = 6.69b USD (from shortLongTermDebtTotal, last quarter) + Leases 143.9m
Net Debt = 6.31b USD (calculated: Debt 6.69b - CCE 385.3m)
Enterprise Value = 48.7b USD (42.4b + Debt 6.69b - CCE 385.3m)
Interest Coverage Ratio = 7.67 (Ebit TTM 1.78b / Interest Expense TTM 232.5m)
EV/FCF = 31.66x (Enterprise Value 48.7b / FCF TTM 1.54b)
FCF Yield = 3.16% (FCF TTM 1.54b / Enterprise Value 48.7b)
FCF Margin = 47.44% (FCF TTM 1.54b / Revenue TTM 3.24b)
Net Margin = 40.74% (Net Income TTM 1.32b / Revenue TTM 3.24b)
Gross Margin = 82.86% ((Revenue TTM 3.24b - Cost of Revenue TTM 555.4m) / Revenue TTM)
Gross Margin QoQ = 83.33% (prev 82.57%)
Tobins Q-Ratio = 8.77 (Enterprise Value 48.7b / Total Assets 5.55b)
Interest Expense / Debt = 3.47% (Interest Expense 232.5m / Debt 6.69b)
Taxrate = 19.54% (292.0m / 1.49b)
NOPAT = 1.44b (EBIT 1.78b * (1 - 19.54%))
Current Ratio = 0.86 (Total Current Assets 1.39b / Total Current Liabilities 1.61b)
Debt / Equity = -2.41 (negative equity) (Debt 6.69b / totalStockholderEquity, last quarter -2.77b)
Debt / EBITDA = 3.17 (Net Debt 6.31b / EBITDA 1.99b)
Debt / FCF = 4.10 (Net Debt 6.31b / FCF TTM 1.54b)
Total Stockholder Equity = -2.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 24.24% (Net Income 1.32b / Total Assets 5.55b)
RoE = -64.13% (negative equity) (Net Income TTM 1.32b / Total Stockholder Equity -2.06b)
RoCE = 41.04% (EBIT 1.78b / Capital Employed (Equity -2.06b + L.T.Debt 6.40b))
RoIC = 36.47% (NOPAT 1.44b / Invested Capital 3.93b)
WACC = 7.35% (E(42.4b)/V(49.0b) * Re(8.07%) + D(6.69b)/V(49.0b) * Rd(3.47%) * (1-Tc(0.20)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.39 | Cagr: -3.49%
[DCF] Terminal Value 76.26% ; FCFF base≈1.50b ; Y1≈1.59b ; Y5≈1.87b
[DCF] Fair Price = 308.0 (EV 28.7b - Net Debt 6.31b = Equity 22.4b / Shares 72.7m; r=8.35% [WACC [floored]]; 5y FCF grow 6.47% → 2.50% )
EPS Correlation: 99.56 | EPS CAGR: 14.49% | SUE: 1.61 | # QB: 3
Revenue Correlation: 99.41 | Revenue CAGR: 12.02% | SUE: 1.42 | # QB: 1
EPS current Quarter (2026-06-30): EPS=4.85 | Chg30d=+0.50% | Revisions=-6% | Analysts=13
EPS next Quarter (2026-09-30): EPS=5.04 | Chg30d=+0.75% | Revisions=+41% | Analysts=13
EPS current Year (2026-12-31): EPS=19.63 | Chg30d=+0.96% | Revisions=+43% | GrowthEPS=+13.6% | GrowthRev=+11.2%
EPS next Year (2027-12-31): EPS=22.45 | Chg30d=+1.83% | Revisions=+43% | GrowthEPS=+14.4% | GrowthRev=+8.7%
[Analyst] Revisions Ratio: +43%